228 related articles for article (PubMed ID: 11450880)
1. Current treatment of high grade osteosarcoma of the extremity: review.
Bacci G; Lari S
J Chemother; 2001 Jun; 13(3):235-43. PubMed ID: 11450880
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy for osteosarcoma of the extremities in preadolescent patients: the Rizzoli Institute experience.
Bacci G; Balladelli A; Palmerini E; Alberghini M; Pollastri P; Galletti S; Mercuri M; Picci P
J Pediatr Hematol Oncol; 2008 Dec; 30(12):908-12. PubMed ID: 19131777
[TBL] [Abstract][Full Text] [Related]
3. Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy.
Bacci G; Briccoli A; Longhi A; Ferrari S; Mercuri M; Faggioli F; Versari M; Picci P
Acta Oncol; 2005; 44(7):748-55. PubMed ID: 16227167
[TBL] [Abstract][Full Text] [Related]
4. Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 cases.
Bacci G; Ferrari S; Ruggieri P; Biagini R; Fabbri N; Campanacci L; Bacchini P; Longhi A; Forni C; Bertoni F
Acta Orthop Scand; 2001 Apr; 72(2):167-72. PubMed ID: 11372948
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: a comparison of results obtained in single-institution and multicenter trials.
Bacci G; Mercuri M; Longhi A; Setola E; Gozzi E; Forni C
Chir Organi Mov; 2004; 89(4):283-92. PubMed ID: 16048049
[TBL] [Abstract][Full Text] [Related]
6. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy in the treatment of osteosarcoma of the extremities: preliminary results in 131 cases treated preoperatively with methotrexate and cisdiamminoplatinum.
Bacci G; Avella M; Capanna R; Boriani S; Dallari D; Galletti S; Giunti A; Madon E; Mancini A; Mercuri M
Ital J Orthop Traumatol; 1988 Mar; 14(1):23-39. PubMed ID: 3235324
[TBL] [Abstract][Full Text] [Related]
8. [Progress and stagnation in chemotherapy protocols for primary osteosarcoma].
Delépine N; Alkallaf S; Cornille H; Markowska B; Delépine G
Ann Med Interne (Paris); 2003 Feb; 154(1):12-24. PubMed ID: 12746655
[TBL] [Abstract][Full Text] [Related]
9. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.
Link MP; Goorin AM; Miser AW; Green AA; Pratt CB; Belasco JB; Pritchard J; Malpas JS; Baker AR; Kirkpatrick JA
N Engl J Med; 1986 Jun; 314(25):1600-6. PubMed ID: 3520317
[TBL] [Abstract][Full Text] [Related]
10. A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity.
Bacci G; Ferrari S; Tienghi A; Bertoni F; Mercuri M; Longhi A; Fiorentini G; Forni C; Bacchini P; Rimondini S; De Giorgi U; Picci P
Eur J Surg Oncol; 2001 Feb; 27(1):98-104. PubMed ID: 11237499
[TBL] [Abstract][Full Text] [Related]
11. Comparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity.
Hong S; Shin SJ; Jung M; Jeong J; Lee YJ; Shin KH; Roh JK; Rha SY
Oncology; 2011; 80(1-2):107-17. PubMed ID: 21677455
[TBL] [Abstract][Full Text] [Related]
12. Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution.
Bacci G; Forni C; Longhi A; Ferrari S; Mercuri M; Bertoni F; Serra M; Briccoli A; Balladelli A; Picci P
J Surg Oncol; 2007 Aug; 96(2):118-23. PubMed ID: 17577221
[TBL] [Abstract][Full Text] [Related]
13. Osteosarcoma in adolescents and young adults: new developments and controversies. Commentary on the use of presurgical chemotherapy.
Link MP
Cancer Treat Res; 1993; 62():383-5. PubMed ID: 8096755
[No Abstract] [Full Text] [Related]
14. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy.
Bacci G; Longhi A; Fagioli F; Briccoli A; Versari M; Picci P
Eur J Cancer; 2005 Dec; 41(18):2836-45. PubMed ID: 16298125
[TBL] [Abstract][Full Text] [Related]
15. Tumor volume increase during preoperative chemotherapy as a novel predictor of local recurrence in extremity osteosarcoma.
Song WS; Jeon DG; Kong CB; Cho WH; Koh JS; Lee JA; Yoo JY; Jung ST; Shin DS; Lee SY
Ann Surg Oncol; 2011 Jun; 18(6):1710-6. PubMed ID: 21222166
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant high-dose methotrexate, cisplatin, and doxorubicin for the management of patients with nonmetastatic osteosarcoma.
Weiner MA; Harris MB; Lewis M; Jones R; Sherry H; Feurer EJ; Johnson J; Lahman E
Cancer Treat Rep; 1986 Dec; 70(12):1431-2. PubMed ID: 3466693
[No Abstract] [Full Text] [Related]
17. Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases.
Bacci G; Longhi A; Forni C; Fabbri N; Briccoli A; Barbieri E; Mercuri M; Balladelli A; Ferrari S; Picci P
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):505-11. PubMed ID: 17118571
[TBL] [Abstract][Full Text] [Related]
18. Current treatment of osteosarcoma.
Ferguson WS; Goorin AM
Cancer Invest; 2001; 19(3):292-315. PubMed ID: 11338887
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy with six drugs (adriamycin, methotrexate, cisplatinum, bleomycin, cyclophosphamide and dactinomycin) for non-metastatic high grade osteosarcoma of the extremities. Results of 32 patients and comparison to 127 patients concomitantly treated with the same drugs in a neoadjuvant form.
Avella M; Bacci G; McDonald DJ; Di Scioscio M; Picci P; Campanacci M
Chemioterapia; 1988 Apr; 7(2):133-7. PubMed ID: 3165057
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy.
Bacci G; Ferrari S; Mercuri M; Bertoni F; Picci P; Manfrini M; Gasbarrini A; Forni C; Cesari M; Campanacci M
Acta Orthop Scand; 1998 Jun; 69(3):230-6. PubMed ID: 9703394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
